The Future of Myeloma Care: Emerging Therapies and Novel Approaches Targeting BCMA

In this expert-authored online activity gain case-based insights on incorporating new findings and novel agents targeting BCMA into the treatment paradigm for patients with multiple myeloma. Also featuring downloadable slides a Clinical Trial Spotlight resource and expert commentaries.

Share

Program Content

Activities

BCMA CAR T-Cell in MM
Targeting BCMA in Myeloma With CAR T-Cell Therapy
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 22, 2020

Expires: September 21, 2021

BCMA ADC/Bispecific Agents in MM
Targeting BCMA in Myeloma With Antibody–Drug Conjugates and Bispecific Agents
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 12, 2020

Expires: November 11, 2021

Activities

Targeting BCMA in Myeloma: Slides
Targeting BCMA in Myeloma: Downloadable Slides
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 26, 2020

Expires: October 25, 2021

ExpressPoints: BCMA in Myeloma
Emerging Therapies and Novel Approaches Targeting BCMA in Myeloma
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 23, 2020

Expires: October 22, 2021

Activities

BCMA: Myeloma Clinical Trials
Clinical Trial Resource Guide To Novel Myeloma Therapies Targeting BCMA
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: November 05, 2020

Expires: November 04, 2021

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Celgene